WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACAD

Based on 11 analysts offering 12 month price targets for Acadia Pharmaceuticals Inc.
Min Forecast
$20.00-21.81%
Avg Forecast
$31.09+21.54%
Max Forecast
$42.00+64.19%

Should I buy or sell ACAD stock?

Based on 11 analysts offering ratings for Acadia Pharmaceuticals Inc.
Buy
Strong Buy
2 analysts 18.18%
Buy
3 analysts 27.27%
Hold
6 analysts 54.55%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACAD stock forecasts and price targets.

ACAD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 9%
9
Strong BuyReiterates$42.00+64.19%2023-08-22
JP Morgan
Top 14%
87
HoldMaintains$29.00+13.37%2023-08-07
Canaccord Genuity
Bottom 9%
9
Strong BuyMaintains$38.00+48.55%2023-08-03
Morgan Stanley
Bottom 20%
20
HoldReiterates$30.00+17.28%2023-08-03
Oppenheimer
Top 5%
96
HoldReiterates$25.00-2.27%2023-08-03
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$33.00+29.01%2023-08-03
RBC Capital
Top 22%
79
BuyMaintains$33.00+29.01%2023-07-14
Citigroup
Top 15%
86
HoldMaintains$27.00+5.55%2023-07-14
JMP Securities
Bottom 4%
4
BuyMaintains$39.00+52.46%2023-07-14
Mizuho
Bottom 6%
6
HoldReiterates$20.00-21.81%2023-06-14

1 of 2

Forecast return on equity

Is ACAD forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.73%

Forecast return on assets

Is ACAD forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.11%

ACAD revenue growth forecast

How is ACAD forecast to perform vs Biotechnology companies and vs the US market?
Company
20.1%
Industry
34.63%
Market
8.12%
ACAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACAD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACAD$25.58$31.09+21.54%Buy
BBIO$26.34$42.00+59.45%Strong Buy
IMGN$15.40$23.00+49.35%Strong Buy
APLS$38.84$72.14+85.77%Buy
CRSP$47.13$73.71+56.41%Buy

Acadia Pharmaceuticals Stock Forecast FAQ

Is Acadia Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: ACAD) stock is to Buy ACAD stock.

Out of 11 analysts, 2 (18.18%) are recommending ACAD as a Strong Buy, 3 (27.27%) are recommending ACAD as a Buy, 6 (54.55%) are recommending ACAD as a Hold, 0 (0%) are recommending ACAD as a Sell, and 0 (0%) are recommending ACAD as a Strong Sell.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.

What is ACAD's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ACAD) forecast ROE is N/A, which is considered weak.

What is ACAD's Price Target?

According to 11 Wall Street analysts that have issued a 1 year ACAD price target, the average ACAD price target is $31.09, with the highest ACAD stock price forecast at $42.00 and the lowest ACAD stock price forecast at $20.00.

On average, Wall Street analysts predict that Acadia Pharmaceuticals's share price could reach $31.09 by Aug 22, 2024. The average Acadia Pharmaceuticals stock price prediction forecasts a potential upside of 21.54% from the current ACAD share price of $25.58.

What is ACAD's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ACAD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.